Eli Lilly (LLY -2.17%) and Novo Nordisk (NVO -1.11%) benefit from innovative treatments for obesity and diabetes.

*Stock prices used were the afternoon prices of Jan. 5, 2025. The video was published on Jan. 7, 2025.